140 related articles for article (PubMed ID: 22965877)
61. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation.
Sadik G; Tanaka T; Kato K; Yamamori H; Nessa BN; Morihara T; Takeda M
J Neurochem; 2009 Jan; 108(1):33-43. PubMed ID: 19014373
[TBL] [Abstract][Full Text] [Related]
62. Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation.
Das R; Balmik AA; Chinnathambi S
ASN Neuro; 2020; 12():1759091420981204. PubMed ID: 33342257
[TBL] [Abstract][Full Text] [Related]
63. Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
Wang L; Liu BJ; Cao Y; Xu WQ; Sun DS; Li MZ; Shi FX; Li M; Tian Q; Wang JZ; Zhou XW
Mol Neurobiol; 2018 Jun; 55(6):4731-4744. PubMed ID: 28717968
[TBL] [Abstract][Full Text] [Related]
64. AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
Georgievska B; Sandin J; Doherty J; Mörtberg A; Neelissen J; Andersson A; Gruber S; Nilsson Y; Schött P; Arvidsson PI; Hellberg S; Osswald G; Berg S; Fälting J; Bhat RV
J Neurochem; 2013 May; 125(3):446-56. PubMed ID: 23410232
[TBL] [Abstract][Full Text] [Related]
65. Caloric restriction mimetic 2-deoxyglucose maintains cytoarchitecture and reduces tau phosphorylation in primary culture of mouse hippocampal pyramidal neurons.
Bele MS; Gajare KA; Deshmukh AA
In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):546-55. PubMed ID: 25678460
[TBL] [Abstract][Full Text] [Related]
66. GSK3beta signalling: casting a wide net in Alzheimer's disease.
Bhat RV; Budd SL
Neurosignals; 2002; 11(5):251-61. PubMed ID: 12566926
[TBL] [Abstract][Full Text] [Related]
67. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ.
Cho JH; Johnson GV
J Biol Chem; 2004 Dec; 279(52):54716-23. PubMed ID: 15494420
[TBL] [Abstract][Full Text] [Related]
68. Glucocorticoid-mediated activation of GSK3β promotes tau phosphorylation and impairs memory in type 2 diabetes.
Dey A; Hao S; Wosiski-Kuhn M; Stranahan AM
Neurobiol Aging; 2017 Sep; 57():75-83. PubMed ID: 28609678
[TBL] [Abstract][Full Text] [Related]
69. GSK3β is involved in the relief of mitochondria pausing in a Tau-dependent manner.
Llorens-Martín M; López-Doménech G; Soriano E; Avila J
PLoS One; 2011; 6(11):e27686. PubMed ID: 22110721
[TBL] [Abstract][Full Text] [Related]
70. NPAS4 Facilitates the Autophagic Clearance of Endogenous Tau in Rat Cortical Neurons.
Fan W; Long Y; Lai Y; Wang X; Chen G; Zhu B
J Mol Neurosci; 2016 Apr; 58(4):401-10. PubMed ID: 26635026
[TBL] [Abstract][Full Text] [Related]
71. miR-125b promotes tau phosphorylation by targeting the neural cell adhesion molecule in neuropathological progression.
Zhang L; Dong H; Si Y; Wu N; Cao H; Mei B; Meng B
Neurobiol Aging; 2019 Jan; 73():41-49. PubMed ID: 30316051
[TBL] [Abstract][Full Text] [Related]
72. GSK3β Impairs KIF1A Transport in a Cellular Model of Alzheimer's Disease but Does Not Regulate Motor Motility at S402.
Gan KJ; Akram A; Blasius TL; Ramser EM; Budaitis BG; Gabrych DR; Verhey KJ; Silverman MA
eNeuro; 2020; 7(6):. PubMed ID: 33067366
[TBL] [Abstract][Full Text] [Related]
73. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.
Smith PY; Hernandez-Rapp J; Jolivette F; Lecours C; Bisht K; Goupil C; Dorval V; Parsi S; Morin F; Planel E; Bennett DA; Fernandez-Gomez FJ; Sergeant N; Buée L; Tremblay MÈ; Calon F; Hébert SS
Hum Mol Genet; 2015 Dec; 24(23):6721-35. PubMed ID: 26362250
[TBL] [Abstract][Full Text] [Related]
74. Toxoplasma gondii Chinese I genotype Wh6 strain infection induces tau phosphorylation via activating GSK3β and causes hippocampal neuron apoptosis.
Tao Q; Wang X; Liu L; Ji Y; Luo Q; Du J; Yu L; Shen J; Chu D
Acta Trop; 2020 Oct; 210():105560. PubMed ID: 32492398
[TBL] [Abstract][Full Text] [Related]
75. DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy.
Chen J; Liu Y; Zhou K; Zhang W; Wen B; Xu K; Liu Y; Chen L; Huang Y; He B; Hang W; Chen J
Biofactors; 2023 Jan; 49(1):173-184. PubMed ID: 36070513
[TBL] [Abstract][Full Text] [Related]
76. Glutamate-responsive translation of dendritic GSK3β mRNA triggers a cycle for amplification of reactivated preexisting GSK3β that is indispensable for tau hyperphosphorylation.
Tanaka T; Ohashi S; Takashima A; Kobayashi S
Neurochem Int; 2020 Oct; 139():104808. PubMed ID: 32711020
[TBL] [Abstract][Full Text] [Related]
77. Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain.
Spears W; Furgerson M; Sweetnam JM; Evans P; Gearing M; Fechheimer M; Furukawa R
BMC Neurosci; 2014 Jun; 15():74. PubMed ID: 24929931
[TBL] [Abstract][Full Text] [Related]
78. Pathologic Thr
Moszczynski AJ; Strong W; Xu K; McKee A; Brown A; Strong MJ
Neurology; 2018 Jan; 90(5):e380-e387. PubMed ID: 29298849
[TBL] [Abstract][Full Text] [Related]
79. Ferroptosis promotes microtubule-associated protein tau aggregation via GSK-3β activation and proteasome inhibition.
Wang S; Jiang Y; Liu Y; Liu Q; Sun H; Mei M; Liao X
Mol Neurobiol; 2022 Mar; 59(3):1486-1501. PubMed ID: 34997541
[TBL] [Abstract][Full Text] [Related]
80. Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine.
Obakan Yerlikaya P; Arısan ED; Coker Gurkan A; Okumus OO; Yenigun T; Ozbey U; Kara M; Palavan Unsal N
Amino Acids; 2021 Sep; 53(9):1373-1389. PubMed ID: 34386848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
